Fecal microbial transplantation: an update
- PMID: 29939968
- DOI: 10.1097/MCO.0000000000000488
Fecal microbial transplantation: an update
Abstract
Purpose of review: The purpose of this article is to provide an update on recent developments in fecal microbiota transplantation (FMT) in the last year.
Recent findings: Although FMT is an accepted treatment for recurrent Clostridium difficile infection (CDI), recently it is also gaining acceptance for the treatment of refractory CDI. FMT is showing promise in ulcerative colitis and is experimental in many other conditions. The optimal practical aspects to enhance the success of FMT are still being established.
Summary: The implication of current research is that the indications of FMT may be extended to other conditions in the future.
Similar articles
-
Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update.Drugs Today (Barc). 2018 Feb;54(2):123-136. doi: 10.1358/dot.2018.54.2.2760765. Drugs Today (Barc). 2018. PMID: 29637938 Review.
-
Any Future for Fecal Microbiota Transplantation as Treatment Strategy for Inflammatory Bowel Diseases?Dig Dis. 2016;34 Suppl 1:74-81. doi: 10.1159/000447379. Epub 2016 Aug 22. Dig Dis. 2016. PMID: 27548724
-
Fecal Microbiota Transplantation.Gastroenterol Clin North Am. 2017 Mar;46(1):171-185. doi: 10.1016/j.gtc.2016.09.012. Gastroenterol Clin North Am. 2017. PMID: 28164849 Review.
-
Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.PLoS One. 2018 Jan 31;13(1):e0190997. doi: 10.1371/journal.pone.0190997. eCollection 2018. PLoS One. 2018. PMID: 29385143 Free PMC article.
-
Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.Transpl Infect Dis. 2016 Aug;18(4):628-33. doi: 10.1111/tid.12550. Epub 2016 Jul 5. Transpl Infect Dis. 2016. PMID: 27214585 Clinical Trial.
Cited by
-
Potential relevance of pig gut content transplantation for production and research.J Anim Sci Biotechnol. 2019 Jul 2;10:55. doi: 10.1186/s40104-019-0363-4. eCollection 2019. J Anim Sci Biotechnol. 2019. PMID: 31304012 Free PMC article. Review.
-
Inflammatory bowel disease and Clostridium difficile infection: clinical presentation, diagnosis, and management.Therap Adv Gastroenterol. 2023 Nov 28;16:17562848231207280. doi: 10.1177/17562848231207280. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 38034098 Free PMC article. Review.
-
The microbiota-gut-brain axis: A promising avenue to foster healthy developmental outcomes.Dev Psychobiol. 2019 Jul;61(5):772-782. doi: 10.1002/dev.21824. Epub 2019 Jan 14. Dev Psychobiol. 2019. PMID: 30640409 Free PMC article. Review.
-
Adherent-invasive Escherichia coli LF82 aggravated intestinal inflammation in colitis mice by affecting the gut microbiota and Th17/Treg cell differentiation balance.Arch Microbiol. 2023 May 5;205(6):218. doi: 10.1007/s00203-023-03570-4. Arch Microbiol. 2023. PMID: 37145326
-
Fecal microbiota transplantation for patients with irritable bowel syndrome: A meta-analysis protocol.Medicine (Baltimore). 2018 Oct;97(40):e12661. doi: 10.1097/MD.0000000000012661. Medicine (Baltimore). 2018. PMID: 30290648 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
